Research Frontiers Incorporated REFR

0.79 0.05 6.76% as of 25 Sep
Market cap
$26.2M
P/E
0.0×
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(154.03%) (113.70%) (115.64%) (87.35%)

+8 more TTM periods

ROA
(79.66%) (69.89%) (65.03%) (65.46%)
ROIC
(4,055.56%) (300.46%) (494.82%) (335.77%)
Return on Tangible Assets
(214.75%) (140.48%) (240.83%) (133.97%)
Average Days of Receivables
116.07 285.12 133.05 110.60
Free Cash Flow per Share
(0.04) (0.04) (0.04) (0.02)
Free Cash Flow
(1.56) (1.45) (1.33) (0.82)
Capital Expenditures
0.00 0.00 0.00 0.00
Piotroski F-Score
1.00 1.00 2.00 2.00
Other line items
Cash ROIC
(70.58%) (47.27%) (83.18%) (31.03%)
Accounts Receivable Turnover
1.76 0.92 2.10 1.73
Accounts Payable Turnover
29.83 44.22 24.21 81.27
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
20.73 14.59 18.31 4.12
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
84.24% 84.74% 54.29% 51.65%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.00% 0.00% 41.40% 33.34%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.69 0.60 0.65 0.43
Depreciation/Fixed assets
62.62 59.48 54.91 43.23
Capex/Depreciation
0.00 0.00 0.00 (0.01)
Revenue per Share
0.02 0.02 0.03 0.04
Operating CF per Share
(0.04) (0.04) (0.04) (0.02)
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
(343.94%) (343.03%) (182.45%) (153.83%)

Fold the line items

Columns are period end dates